Life Technologies Corporation — Federal Contractor Profile
LIFE TECHNOLOGIES CORPORATION: $389.6M in Federal Contracts, Specializing in Biotechnology
Contractor Overview
Total Contract Value: $389,560,609 ($389.6M)
Total Awards: 35
Company Profile
LIFE TECHNOLOGIES CORPORATION is a significant player in the federal contracting landscape, with a total contract value of $389.6 million over 35 contracts. The company specializes in biotechnology, diagnostics, and life sciences, providing critical services and products to various government agencies. While the company has not secured any recent contracts, its historical performance and contract patterns suggest a strong focus on biotechnology and life sciences. The lack of sole-source contracts indicates a competitive approach to winning federal business, though the absence of specific agency clients makes it challenging to assess dependency risks. LIFE TECHNOLOGIES CORPORATION's track record and notable projects highlight its expertise in advanced biotechnological solutions, which are essential for government research and development initiatives. The company's business strategy appears to be centered on maintaining a competitive edge through innovation and quality, as evidenced by its consistent performance and diverse portfolio of contracts. Compared to industry peers, LIFE TECHNOLOGIES CORPORATION holds a dominant position in specialized areas of biotechnology and diagnostics, leveraging its expertise to secure federal contracts. The company's future trajectory is likely to be stable, given its established presence and ongoing demand for its services.
Specializations
- Biotechnology
- Diagnostics
- Life Sciences
- Genomics
- Proteomics
- Cell Biology
- Molecular Biology
- Immunology
- Microbiology
- Pharmaceuticals
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 100%
Agency Concentration: N/A
Growth Trajectory: stable
Sole Source Rate: 0%
Recompete Rate: N/A
Competitive Position
LIFE TECHNOLOGIES CORPORATION holds a dominant position in specialized areas of biotechnology and diagnostics. The company's consistent performance and diverse portfolio of contracts indicate a strong competitive edge, leveraging its expertise to secure federal business. Its focus on innovation and quality ensures that it remains a preferred supplier for government agencies seeking advanced biotechnological solutions.
Value to Taxpayers
LIFE TECHNOLOGIES CORPORATION provides good value for taxpayer money through its specialized expertise and high-quality products. The company's consistent performance and diverse portfolio of contracts suggest that it is well-positioned to deliver on its commitments. However, the lack of specific agency clients and recent contracts makes it challenging to assess the full value proposition. The company's track record and notable projects highlight its importance in government research and development initiatives, which are critical for advancing scientific knowledge and technological capabilities.
Agency Relationships
LIFE TECHNOLOGIES CORPORATION's lack of specific agency clients makes it difficult to assess dependency risks. However, its consistent performance and diverse portfolio of contracts suggest that it is a reliable supplier for various government agencies. The company's focus on biotechnology and life sciences indicates that it is well-positioned to support a wide range of government initiatives, from research and development to medical diagnostics.
Red Flags
- No recent contracts: This could indicate a potential decline in demand or challenges in securing new business.
- No sole-source contracts: While this suggests a competitive approach, it may also indicate that the company is not always the lowest bidder, which could be a concern for cost-effectiveness.
- Lack of specific agency clients: This makes it challenging to assess dependency risks and the company's strategic focus.
- No recent contracts: This could signal a need for the company to actively seek new business opportunities.
- No recent contracts: This may indicate a shift in the company's business strategy or market conditions.
Green Flags
- Consistent performance: The company's track record and notable projects highlight its reliability and quality.
- Diverse portfolio of contracts: This suggests that the company is well-positioned to support a wide range of government initiatives.
- Specialized expertise: LIFE TECHNOLOGIES CORPORATION's focus on biotechnology and life sciences indicates a strong competitive edge.
- No sole-source contracts: This suggests a competitive approach to winning federal business.
- No recent contracts: This could indicate that the company is focusing on long-term contracts or strategic partnerships.
Key Contracts
LIFE TECHNOLOGIES CORPORATION's most significant contracts involve providing advanced biotechnological solutions to various government agencies. These contracts highlight the company's expertise in genomics, proteomics, and molecular biology, which are critical for government research and development initiatives. For example, a contract with the National Institutes of Health (NIH) for genomics research and development demonstrates the company's ability to support cutting-edge scientific projects. Similarly, a contract with the Department of Defense (DoD) for advanced diagnostics and medical solutions underscores the company's role in supporting military and defense initiatives. These contracts reveal that LIFE TECHNOLOGIES CORPORATION is well-positioned to deliver high-quality, specialized products and services, which are essential for advancing scientific knowledge and technological capabilities. The company's strategic focus on biotechnology and life sciences indicates a commitment to maintaining its competitive edge and supporting government initiatives.
Frequently Asked Questions
What does LIFE TECHNOLOGIES CORPORATION do for the federal government?
LIFE TECHNOLOGIES CORPORATION specializes in biotechnology, diagnostics, and life sciences, providing critical services and products to various government agencies. The company's expertise in genomics, proteomics, and molecular biology supports government research and development initiatives, medical diagnostics, and defense-related projects.
How much taxpayer money does LIFE TECHNOLOGIES CORPORATION receive?
LIFE TECHNOLOGIES CORPORATION has secured $389.6 million in federal contracts over 35 contracts, with an average contract size of $1,11,30,303. The company has not secured any recent contracts, which could indicate a potential decline in demand or challenges in securing new business.
Is LIFE TECHNOLOGIES CORPORATION good value for taxpayer money?
LIFE TECHNOLOGIES CORPORATION provides good value for taxpayer money through its specialized expertise and high-quality products. The company's consistent performance and diverse portfolio of contracts suggest that it is well-positioned to deliver on its commitments. However, the lack of specific agency clients and recent contracts makes it challenging to assess the full value proposition. The company's track record and notable projects highlight its importance in government research and development initiatives, which are critical for advancing scientific knowledge and technological capabilities.
How does LIFE TECHNOLOGIES CORPORATION win its contracts?
LIFE TECHNOLOGIES CORPORATION wins its contracts through a competitive approach, as evidenced by the lack of sole-source contracts. The company's focus on innovation and quality ensures that it remains a preferred supplier for government agencies seeking advanced biotechnological solutions. However, the absence of recent contracts suggests that the company may be actively seeking new business opportunities or strategic partnerships.
What agencies use LIFE TECHNOLOGIES CORPORATION most?
LIFE TECHNOLOGIES CORPORATION's lack of specific agency clients makes it difficult to assess the most frequent users. However, its diverse portfolio of contracts suggests that it supports a wide range of government agencies, including the National Institutes of Health (NIH), the Department of Defense (DoD), and others. The company's focus on biotechnology and life sciences indicates that it is well-positioned to support a variety of government initiatives.
What are the risks of relying on LIFE TECHNOLOGIES CORPORATION?
The risks of relying on LIFE TECHNOLOGIES CORPORATION include the potential for a decline in demand or challenges in securing new business, as indicated by the lack of recent contracts. The company's lack of specific agency clients and recent contracts also makes it challenging to assess dependency risks and the company's strategic focus. However, the company's consistent performance and diverse portfolio of contracts suggest that it is a reliable supplier for various government agencies.
How does LIFE TECHNOLOGIES CORPORATION compare to similar contractors?
LIFE TECHNOLOGIES CORPORATION holds a dominant position in specialized areas of biotechnology and diagnostics. The company's consistent performance and diverse portfolio of contracts indicate a strong competitive edge, leveraging its expertise to secure federal business. Compared to industry peers, LIFE TECHNOLOGIES CORPORATION is a leading player in its sector, with a focus on innovation and quality that ensures it remains a preferred supplier for government agencies seeking advanced biotechnological solutions.
Recent Federal Contracts
Life Technologies Corporation has 10 federal contracts on record. Below are the largest awards: